Liberty Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-128
Closed -$48K 750
2021
Q3
$48K Buy
128
+106
+482% +$39.1K 0.02% 435
2021
Q2
$5K Sell
22
-136
-86% -$24.3K ﹤0.01% 793
2021
Q1
$24K Hold
158
0.01% 426
2020
Q4
$24K Buy
158
+4
+3% +$405 0.01% 423
2020
Q3
$11K Buy
+154
New +$10.7K 0.01% 501

Other funds holding MRNA

Liberty Wealth Management's MRNA Position: Q4 2021 in Review

Liberty Wealth Management sold out of Moderna (MRNA) in Q4 2021, closing a stake of 128 shares — an estimated $48K sold.

Liberty Wealth Management first reported a position in MRNA in Q3 2020 and held it in 5 quarters. The position peaked at $48K in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Liberty Wealth Management reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Liberty Wealth Management sold 128 Moderna shares in Q4 2021, an estimated $48K.
  • Liberty Wealth Management first reported a position in Moderna in Q3 2020 and held it in 5 quarters.
  • Liberty Wealth Management's Moderna position peaked at $48K in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.